The Patent Finder

Catalyst Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Catalyst Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 3 of 3 · Back to Catalyst Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,772,497Method for producing 1, 2-dihydropyridine-2-one compound
Term ended
Term ended May 16, 2026 · From the USPTO record
Term endedTerm ended May 16, 2026From the USPTO record
US 9,045,426Method for Producing 1,2-Dihydropyridine-2-ONE Compound
Term ended
Term ended Jul 5, 2025 · Medium confidence
Term endedTerm ended Jul 5, 2025Medium confidence
US 6,949,5711,2-Dihydropyridine Compounds, Process for Preparation of the Same and Use Thereof
Term ended
Term ended May 23, 2025 · High confidence
Term endedTerm ended May 23, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited